Prescribing Antibiotics Is Un-Ethical Medical Practice
It is now mandatory to identify and stop GPs abusing antibiotics. I am more concerned about the private surgeries which are likely to be the major threat. It is often difficult not to prescribe as the demand for antibiotics is likely to increase because the patients have lost faith in primary care in the NHS.
Knowing prescribe antibiotics to patients because of the increasing danger posed to general public health by the growing resistance some infections are showing to many established types of antibiotics. It is unethical to prescribe drugs that may result in harm. The GMC must make it clear to doctors that they may be penalised if found to abuse antibiotics.
Here, for the first time, Guardian has published an article “Antibiotic prescription by GP practice” with a map showing the areas where GPs are most, or least, likely to give a patient a prescription for antibiotics.
Antibiotics are often given by doctors for coughs, colds and flu knowing they do not benefit patients. These are symptoms that are associated with various conditions and does not mean you have an infection that need antibiotic. Viral infections often produce very high temperature and the illness last for a week.
Virus seldom kill but use animals to help them multiply and spread their population in this universe. Bacterial infections (pneumonia, meningitis and appendicitis) often follow viral infections and produce mild temperature, release a toxin which can result in septic shock and death.
Viral infection often are prolonged and may result in complications (secondry bacterial infections, enchephalitis), weakness (ME, Glandular fever) or live in your body for ever (HIV, Chicken pox).
Prescribing an antibiotic for all these symptoms is making antibiotic resistant bacteria stronger and colonise in your body. Their cell wall is said to become more thicker and no drug can penetrate to kill them. This is likely to make things worse for scientists to develop new methods to stop them spreading and killing health adults. Partially treated bacterial infection can be more serious than the ones which you don’t treat.
Antibiotics kill good germs and create more space for antibiotic resistant bacteria to grow. When MRSA die, they release the enzymes and their plasmid which can be engulfed by normal bacteria. Plasmid helps sensitive bacteria develop resistance (similar to you picking up a gun left in your garden by a dead killer). Once these antibiotic resistant bacteria colonizes in your body, you will not be able to get rid of them. They pose danger to you and the loved ones who are in contact with you.
We know 48% of doctors and nurses managing MRSA infected patients are colonized with the same bacteria. Washing hands and cleaning nose will reduce this number to 23% and they can never eradicate this colony.
We are publishing these information in our website because the medical journals will not publish any articles that challenge pharmaceutical and medical device manufacturers. Most medical journals thrive on the revenue collected from advertisements and sponsorship. Intensive care journals have offered to write about our medical devices that have proved to benefit healthcare workers and you if we agree to pay to advertise.
Antibiotic Research & Development
Since 1940s, the world changed and in 1980s the pace of growth exhilarated and now the progress is fast declining but more rapid than the growth. It was thirty years ago, when we were facing the terrifying prospect of an untreatable disease known as AIDS, big drug makers scented an opportunity and raced to develop new medicines.
Now the world confronts another crisis, this time one of antibiotic resistance, the industry is doing the opposite. It is cutting research in a field that offers little hope for making money.
Antibiotics have become victims of their own success. Seen as cheap, routine treatments, they are overprescribed and taken haphazardly, creating “superbugs” they can no longer fight. These “superbugs” are growing, but are not yet widespread, so the costly research needed to combat them is not worthwhile. Medical experts say this dilemma could return medicine to an era before Alexander Fleming discovered penicillin in 1928.
Fixing the problem will need both faster approval of last-resort drugs and new ways to guarantee rewards for companies, according to both industry leaders and public health officials who have been sounding the alarm.
Unfortunately for the world, only four companies are currently developing antibiotics. The market for a new antibiotic is very small, the rewards are not there and so the capital is not flowing. It’s about the sheer amount of money people are prepared to pay for a drug. In cancer, people pay $30,000, $50,000 or $80,000 (per patient) for a drug, but for an antibiotic it is likely to be only a few hundred dollars.”
The steady rise in resistance in the last five years represented a “ticking time bomb” that ranks alongside terrorism as a threat to the nation. This is a long cycle time antibiotic business. Even if we get this absolutely brilliantly tuned up it is going to be a five to 10 year journey,” he said.
Aggressive Antibiotic Treatment Makes Bacteria’s Defenses Stronger
Using large doses and combination of antibiotics because help of bacteria quickly develop resistance, but how quick?
The standard treatment strategy for a bacterial infection is to use large doses with a combination of antibiotics to keep bacterial cells from multiplying and the infection from spreading.
New research from the University of Exeter in the UK and Kiel University in Germany says that may be the wrong approach. Using highly potent, combined antibiotic treatments could speed up bacteria’s resistance to these drugs, which is an increasing health concern worldwide. . PLOS Biology,
CDC (Centers for Disease Control and Prevention) says that controlling and combating the spread of life-threatening bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), remains one of their top priorities.
In a laboratory setting, Exeter and Kiel researchers gave E. coli bacteria both single and combination antibiotic treatments. They found that the stronger treatments sped up drug resistance, and that the most effective treatments worked on the first day but could become ineffective as quickly as day two and nearly useless by day five.
Researchers found that drug-resistant bacteria replicate fastest when competing bacteria are eliminated by the aggressive antibiotic therapies. Invasive species thrive well soon after removing the competition.
The experiment was stopped the experiments because some of the treatments made antibiotics lose potency very fast; sometimes within a day. Bacteria that remained after the initial antibiotic treatment quickly replicated their treatment-resistant genes, and that the copies of those genes appeared more quickly with a combination treatment, “resulting in the rapid evolution of very resistant bacteria,”
Bacteria didn’t just make copies of the genes they needed, they copied other genes as well, increasing resistance to antibiotics that they weren’t even treated with.”
Scary Reality of Antibiotic Resistance
The World Economic Forum has called antibiotic resistance “arguably the greatest risk” to human health.
Both the over-prescription of antibiotics—to treat the common cold and other viral infections—and the use of antibiotics in livestock have been linked to the increased ineffectiveness of current antibiotic treatments in humans.
In 2009, more than 6.5 million pounds of antibiotics were administered to U.S. patients, and in 2010, 28.6 million pounds were given to animals, according to perspective paper published earlier this year in The New England Journal of Medicine.
The Best Method To Stop Abuse Is To Avoid Wasted Consultaions